Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses
Michelle A. Lowes, Chris B. Russell, Roland Martinꝉ, et al.
Trends in Immunology (2013) Vol. 34, Iss. 4, pp. 174-181
Open Access | Times Cited: 466

Showing 1-25 of 466 citing articles:

Psoriasis
Wolf‐­Henning Boehncke, Michael P. Schön
The Lancet (2015) Vol. 386, Iss. 9997, pp. 983-994
Closed Access | Times Cited: 2133
Immunology of Psoriasis
Michelle A. Lowes, Mayte Suárez‐Fariñas, James G. Krueger
Annual Review of Immunology (2014) Vol. 32, Iss. 1, pp. 227-255
Open Access | Times Cited: 1405
IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases
Michele W.L. Teng, Edward P. Bowman, Joshua McElwee, et al.
Nature Medicine (2015) Vol. 21, Iss. 7, pp. 719-729
Closed Access | Times Cited: 779
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
Emma Guttman‐Yassky, Robert Bissonnette, Benjamin Ungar, et al.
Journal of Allergy and Clinical Immunology (2018) Vol. 143, Iss. 1, pp. 155-172
Open Access | Times Cited: 543
Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation
Lorena Riol‐Blanco, José Ordovás-Montañés, Mario Perro, et al.
Nature (2014) Vol. 510, Iss. 7503, pp. 157-161
Open Access | Times Cited: 501
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
Kristian Reich, Kim Papp, Andrew Blauvelt, et al.
The Lancet (2017) Vol. 390, Iss. 10091, pp. 276-288
Closed Access | Times Cited: 477
Transcriptome Analysis of Psoriasis in a Large Case–Control Sample: RNA-Seq Provides Insights into Disease Mechanisms
Bingshan Li, Lam C. Tsoi, William R. Swindell, et al.
Journal of Investigative Dermatology (2014) Vol. 134, Iss. 7, pp. 1828-1838
Open Access | Times Cited: 364
Characterization of Innate Lymphoid Cells in Human Skin and Blood Demonstrates Increase of NKp44+ ILC3 in Psoriasis
Federica Villanova, Barry Flutter, Isabella Tosi, et al.
Journal of Investigative Dermatology (2013) Vol. 134, Iss. 4, pp. 984-991
Open Access | Times Cited: 353
The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis
Cristina Albanesi, Stefania Madonna, Paolo Gisondi, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 347
Activation of the Aryl Hydrocarbon Receptor Dampens the Severity of Inflammatory Skin Conditions
Paola Di Meglio, João H. Duarte, Helena Ahlfors, et al.
Immunity (2014) Vol. 40, Iss. 6, pp. 989-1001
Open Access | Times Cited: 334
Advances in the pathogenesis of psoriasis: from keratinocyte perspective
Xue Zhou, Youdong Chen, Lian Cui, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 329
The Immunopathogenesis of Psoriasis
Jaehwan Kim, James G. Krueger
Dermatologic Clinics (2014) Vol. 33, Iss. 1, pp. 13-23
Closed Access | Times Cited: 292
Scanning the Immunopathogenesis of Psoriasis
Andrea Chiricozzi, Paolo Romanelli, Elisabetta Volpe, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 1, pp. 179-179
Open Access | Times Cited: 289
Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis
Howard Sofen, Stacy Smith, Robert Matheson, et al.
Journal of Allergy and Clinical Immunology (2014) Vol. 133, Iss. 4, pp. 1032-1040
Open Access | Times Cited: 288
Psoriasis
Paola Di Meglio, Federica Villanova, Frank O. Nestlé
Cold Spring Harbor Perspectives in Medicine (2014) Vol. 4, Iss. 8, pp. a015354-a015354
Open Access | Times Cited: 280
Current knowledge on psoriasis and autoimmune diseases
Thomas S. McCormick, Nilmarie Ayala‐Fontanez, David Soler
Psoriasis Targets and Therapy (2016), pp. 7-7
Open Access | Times Cited: 240
IL-36γ (IL-1F9) Is a Biomarker for Psoriasis Skin Lesions
Angelo Massimiliano D’Erme, Dagmar Wilsmann‐Theis, Julia Wagenpfeil, et al.
Journal of Investigative Dermatology (2014) Vol. 135, Iss. 4, pp. 1025-1032
Open Access | Times Cited: 230
Lipidomics profiling reveals the role of glycerophospholipid metabolism in psoriasis
Chunwei Zeng, Bo Wen, Guixue Hou, et al.
GigaScience (2017) Vol. 6, Iss. 10, pp. 1-11
Open Access | Times Cited: 216
β-Defensin 2 is a responsive biomarker of IL-17A–driven skin pathology in patients with psoriasis
Frank Kolbinger, Christian Loesche, Marie‐Anne Valentin, et al.
Journal of Allergy and Clinical Immunology (2016) Vol. 139, Iss. 3, pp. 923-932.e8
Open Access | Times Cited: 207
Psoriasis: Keratinocytes or Immune Cells – Which Is the Trigger?
Farida Benhadou, Dillon Mintoff, V. del Mármol
Dermatology (2018) Vol. 235, Iss. 2, pp. 91-100
Open Access | Times Cited: 201
Psoriasis: A STAT3-Centric View
Enzo Calautti, Lidia Avalle, Valeria Poli
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 1, pp. 171-171
Open Access | Times Cited: 200
Critical role of environmental factors in the pathogenesis of psoriasis
Jinrong Zeng, Shuaihantian Luo, Yumeng Huang, et al.
The Journal of Dermatology (2017) Vol. 44, Iss. 8, pp. 863-872
Open Access | Times Cited: 194
Polyphenols in the treatment of autoimmune diseases
Haroon Khan, Antoni Sureda, Tarun Belwal, et al.
Autoimmunity Reviews (2019) Vol. 18, Iss. 7, pp. 647-657
Open Access | Times Cited: 184
Evidence that a neutrophil–keratinocyte crosstalk is an early target of IL‐17A inhibition in psoriasis
Kristian Reich, Kim Papp, Robert Matheson, et al.
Experimental Dermatology (2015) Vol. 24, Iss. 7, pp. 529-535
Open Access | Times Cited: 181
IL-12 protects from psoriasiform skin inflammation
Paulina Kulig, Stephanie Musiol, Sandra N. Freiberger, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 175
Page 1 - Next Page

Scroll to top